Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell LymphomaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasmRecruitingPhase 22024-09-04NCT06341556

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Fudan University653

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Fudan University Shanghai Cancer CenterShanghaiChina257
Shanghai Cancer CenterShanghaiChina6